Search
Taladegib
go.drugbank.com/drugs/DB12550InvestigationalTaladegib has been used in trials studying the treatment of Solid Tumor, COLON CANCER, BREAST CANCER, Advanced Cancer, and Rhabdomyosarcoma, among others.
Fluocinolone
go.drugbank.com/drugs/DB12553InvestigationalFluocinolone has been used in trials studying the treatment and prevention of Candida Infection, Oral Lichen Planus, Macular Degeneration, and Choroidal Neovascularization.
Samatasvir
go.drugbank.com/drugs/DB12660InvestigationalSamatasvir has been used in trials studying the treatment of Hepatitis C, Chronic, Chronic Hepatitis C Virus, and Chronic Hepatitis C Infection.
REP8839
go.drugbank.com/drugs/DB05224ExperimentalREP8839 is a novel methionyl-tRNA synthetase (MetS) inhibitor being developed by Replidyne (GlaxoSmithKline licensed REP8839 to Replidyne in June of 2003).
2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine
go.drugbank.com/drugs/DB08398InvestigationalPhIP (2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine) has been used in trials studying the basic science of Pancreas Cancer.
Betacetylmethadol
go.drugbank.com/drugs/DB01522ExperimentalIllicitIt is used mainly in the treatment of narcotic dependence. [PubChem]
Mirogabalin
go.drugbank.com/drugs/DB11825InvestigationalMirogabalin has been used in trials studying the treatment of Post-herpetic Neuralgia, Pain Associated With Fibromyalgia, and Diabetic peripheral neuropathic pain.
Emixustat
go.drugbank.com/drugs/DB12608InvestigationalEmixustat has been used in trials studying the treatment of Geographic Atrophy, Age-Related Macular Degeneration, and Dry Age-related Macular Degeneration.
Prifinium
go.drugbank.com/drugs/DB13254ExperimentalPrifinium is an antimuscarinic agent with antispasmodic and antiemetic properties. It may be useful for the treatment of irritable bowel syndrome [A175027].
Uridine monophosphate
go.drugbank.com/drugs/DB03685InvestigationalA uracil nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position.